The 28 references in paper A. Shutov I., V. Serov A., А. Шутов М., В. Серов А. (2009) “КАРДИОРЕНАЛЬНЫЙ И РЕНОКАРДИАЛЬНЫЙ СИНДРОМЫ // CARDIORENAL AND RENOCARDIAL SYNDROMES” / spz:neicon:nefr:y:2009:i:4:p:59-63

1
Ronco C, Haapio C, House AA et al. Саrdiorenal syndrome. J Am Coll Cardiol 2008;52(19):1527-1539
(check this in PDF content)
2
Национальные Рекомендации ВНОК и ОССН по ди­ агностике и лечению ХСН (второй пересмотр). Сердечная недостаточность. 2007;1:4-41
(check this in PDF content)
3
National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification. Am J Kidney Dis 2002; 39 (suppl 1):S1-S266
(check this in PDF content)
4
Butler J. Addressing the challenges of cardiorenal syndrome. Clevelend Clinic Journal of Medicine 2006; 73(5): 485-491
(check this in PDF content)
5
Shlipak MG, Massie BM. The Clinical Challenge of Cardiorenal Syndrome. Circulation 2004;110:1514-1517
(check this in PDF content)
6
Portoles PJ, Cuevas BX. Cardiorenal syndrome. Nefrologia 2008; 28 [Suppl 3]: 29-32
(check this in PDF content)
7
Bongartz LG, Cramer MJ, Doevendans PA et al. The severe cardiorenal syndrome: ‘Guyton revisited’. Eur Heart J 2005; 26:11-17
(check this in PDF content)
8
Kociol R, Rogers J, Shaw A. Organ cross talk in the critically ill: the heart and kidney. Blood Purif 2009; 27(4):311- 320.
(check this in PDF content)
9
Мухин НА, Фомин ВВ, Моисеев СВ и др. Кардиоре­ нальный синдром при ишемической болезни почек (ате­ росклеротической реноваскулярной гипертонии) Тер архив 2008; 8: 30-38
(check this in PDF content)
10
Schrier RW. Cardiorenal versus renocardiac syndrome: Is there a difference? Nat Clin Pract Nephrol 2007; 3: 637
(check this in PDF content)
11
Kimmenade RRJ, Pinto Y, Januzzi JL. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the ‘cardio-renal syndrome’?
(check this in PDF content)
12
Knight EL, Glynn RJ, McIntyre KM et al. Predictors of decreased renal function with heart failure during angiotensin­ converting enzyme inhibitor therapy: results from studies of left ventricular dysfunction. Am Heart J 1999; 138: 849-855
(check this in PDF content)
13
Dries DL, Exner DV, Domaski MJ et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35: 681-689
(check this in PDF content)
14
Серов ВА, Шутов АМ, Сучков ВН и др. Прогности­ ческое значение снижения функции почек у больных с хро­ нической сердечной недостаточностью. Нефрология и диализ 2008; 3-4: 214-218
(check this in PDF content)
15
Hillege HL, Nisch D, Pfeffer MA et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113: 671-678
(check this in PDF content)
16
Amsalem Y, Garty M, Schwartz R. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008; 29: 1029-1036
(check this in PDF content)
17
Francis G. Acute decompensated heart failure: The cardiorenal syndrome. Clev Clin J Med 2006; 73[Suppl 2]: S8- 13
(check this in PDF content)
18
Bhatia RS, Ty JV, Lee DS et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269
(check this in PDF content)
19
Brosius FC, Hostetter TH, Kelepouris E et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Circulation 2006;114(10):1083-1087
(check this in PDF content)
20
Butler J, Forman DE, Abraham WT et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147:331-338
(check this in PDF content)
21
Neuberg GW, Miller AB, O’Connor CM et al. Diuretic resistance predicts mortality in patients with advanced heart failure (Prospective Randomized Amlodipine Survival Evaluation). Am Heart J 2002; 144: 31-38
(check this in PDF content)
22
Liang KV, Williams AW, Greene EL, Redfield MM. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 2008; 36: S75-88
(check this in PDF content)
23
Heymes C, Bendall JK, Ratajczak P et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003; 41: 2164-2171
(check this in PDF content)
24
Moe GW, Rouleau JL, Nguyen QT et al. Role of endothelins in congestive heart failure. Can J Physiol Pharmacol 2003; 81: 588-597
(check this in PDF content)
25
Guyton AC. The surprising kidney-fluid mechanism for pressure control-its infinite gain! Hypertension 1990;16:725- 730
(check this in PDF content)
26
Pokhrel N, Maharjan N, Dhakal B, Arora RR. Cardiorenal syndrome: A literature review. Exp Clin Cardiol 2008;13(4):165- 170
(check this in PDF content)
27
Шутов АМ, Серов ВА, Гердт АМ и др. Хроническая болезнь почек предрасполагает к фибрилляции предсер­ дий у больных с хронической сердечной недостаточнос­ тью. Нефрология 2008; 4: 49-53
(check this in PDF content)
28
Диагностика и лечение метаболического синдрома. Российские рекомендации, Москва, 2007. Кардиоваскуляр­ ная терапия и профилактика 2007; 6(приложение 2) Поступила в редакцию 13.07.2009 г. Принята в печать 23.11.2009 г.
(check this in PDF content)